unknown
Stage
About
Adaptimmune develops engineered T-cell therapies designed to treat cancer by arming immune cells to recognize and destroy cancer cells.
Explore Adaptimmune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.